Johnson & Johnson Medical Technology’s global history can be traced back to the beginning of Johnson & Johnson’s establishment in the United States in 1886. As one of the healthcare companies with wide business worldwide, Johnson & Johnson originated from the production of sterile surgical sutures and auxiliary materials. For more than a century, Johnson & Johnson Medical Technology has always been committed to becoming a world-leading medical technology innovator and bringing far-reaching significance to human health with rich and diverse professional accumulation, mission-significant scientific innovation, and high enthusiasm for human health. Influence, let people all over the world have a healthy and beautiful life. At present, in the fields of surgery, cardiovascular and professional solutions, orthopedics and ophthalmology, Johnson & Johnson Medical Technology continues to innovate and deepen its efforts around the world, striving to solve unmet medical needs, reimagine the future of human health, and allow medical solutions to Smarter, more minimally invasive, more personalized, protect life and light up every beam of hope.

In 1994, Johnson & Johnson Medical Technology entered the Chinese market. Currently, Johnson & Johnson Medical Technology has more than 5,000 employees in China, of which 85% are new generation employees. It is headquartered in Shanghai and has offices in Beijing, Guangzhou and other places. On the road of growing together with China's medical and health industry, we will continue to expand and improve our product layout and supply chain production capacity in China. At present, medical technology has become Johnson & Johnson's largest business segment in China.

In recent years, Johnson & Johnson Medical Technology has continued to deepen its layout of end-to-end supply chain systems in China, improve local intelligent manufacturing capabilities, introduce global advanced product, technology and quality management experience, and help the industry develop at a high quality and high speed. The integrated supply chain production base located in Suzhou Industrial Park is a large comprehensive industrial park of Johnson & Johnson Medical Technology in China. It integrates the research and development and manufacturing of medical equipment, technological innovation and cooperation, global shared services, regional procurement and supplier management. and other diversified business functions, among which the intelligent manufacturing factory produces a series of innovative products such as surgery and orthopedics, responds to local demand and supplies globally.

Johnson & Johnson Medical Technology not only focuses on cultivating and upgrading local intelligent manufacturing capabilities, but also further focuses on local R&D and innovation capabilities. In addition to Suzhou Supply Chain Base, Guangzhou Beixiu Biotechnology Co., Ltd., a wholly-owned subsidiary of Johnson & Johnson, is a biotechnology company specializing in technology development, research and production of pig-derived biological products. Beixiu independently developed the technology to extract fibrinogen and thrombin from mammalian blood, which is the world's first biomedical innovation.

On the road to growing together with China's medical and healthcare industry, Johnson & Johnson Medical Technology has deepened the professional education and training of Chinese professional medical staff and is committed to becoming a trustworthy partner of Chinese medical staff. In line with the purpose of "exploring human technology and caring about human health", three Johnson & Johnson Medical Technology Professional Education Academic Centers located in Beijing, Shanghai and Boao Lecheng Medical Pilot Zone and the digital doctor training and education platform "Ling Yimai" provide professional knowledge, Training to adapt to China's medical service environment and innovative medical education forms will be promoted to the professional and systematic development of continuing medical education.

In addition, Johnson & Johnson Medical Technology is also actively working with partners from all walks of life to promote innovation cooperation, accelerate the transformation of innovative results, and serve patients. As part of Johnson & Johnson's China Innovation Engine Strategy, Johnson & Johnson cooperates with local companies to leverage digital technologies such as artificial intelligence, surgical robots, and big data to assist doctors in more effective perioperative work and establish localized digital surgical solutions.